Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome
Although knowledge on inflammatory signaling pathways driving cancer initiation and progression has been increasing, molecular mechanisms in hepatocarcinogenesis are still far from being completely understood. Hepatocyte-specific deletion of the MAPKKK Tak1 in mice recapitulates important steps of h...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 January 2022
|
| In: |
Cancers
Year: 2022, Jahrgang: 14, Heft: 2, Pages: 1-21 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14020430 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14020430 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/2/430 
|
| Verfasserangaben: | Dirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Tiemo Sven Gerber, Bruno Christian Köhler, Federico Nichetti, Annekathrin Ludt, Nadine Gehrke, Jörn Markus Schattenberg, Stefan Heinrich, Wilfried Roth and Beate Katharina Straub |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1817200453 | ||
| 003 | DE-627 | ||
| 005 | 20230720103356.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220921s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers14020430 |2 doi | |
| 035 | |a (DE-627)1817200453 | ||
| 035 | |a (DE-599)KXP1817200453 | ||
| 035 | |a (OCoLC)1361696334 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ridder, Dirk |d 1979- |e VerfasserIn |0 (DE-588)140792775 |0 (DE-627)621611506 |0 (DE-576)320797058 |4 aut | |
| 245 | 1 | 0 | |a Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome |c Dirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Tiemo Sven Gerber, Bruno Christian Köhler, Federico Nichetti, Annekathrin Ludt, Nadine Gehrke, Jörn Markus Schattenberg, Stefan Heinrich, Wilfried Roth and Beate Katharina Straub |
| 246 | 3 | 3 | |a Transforming growth factor-beta activated kinase one (Tak one) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome |
| 264 | 1 | |c 15 January 2022 | |
| 300 | |a 21 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.09.2022 | ||
| 520 | |a Although knowledge on inflammatory signaling pathways driving cancer initiation and progression has been increasing, molecular mechanisms in hepatocarcinogenesis are still far from being completely understood. Hepatocyte-specific deletion of the MAPKKK Tak1 in mice recapitulates important steps of hepatocellular carcinoma (HCC) development, including the occurrence of cell death, steatohepatitis, dysplastic nodules, and HCCs. However, overactivation of Tak1 in mice upon deletion of its deubiquitinase Cyld also results in steatohepatitis and HCC development. To investigate Tak1 and Cyld in human HCCs, we created a tissue microarray to analyze their expression by immunohistochemistry in a large and well-characterized cohort of 871 HCCs of 561 patients. In the human liver and HCC, Tak1 is predominantly present as its isoform Tak1A and predominantly localizes to cell nuclei. Tak1 is upregulated in diethylnitrosamine-induced mouse HCCs as well as in human HCCs independent of etiology and is further induced in distant metastases. A high nuclear Tak1 expression is associated with short survival and vascular invasion. When we overexpressed Tak1A in Huh7 cells, we observed increased tumor cell migration, whereas overexpression of full-length Tak1 had no significant effect. A combined score of low Cyld and high Tak1 expression was an independent prognostic marker in a multivariate Cox regression model. | ||
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a Cyld | |
| 650 | 4 | |a HCC | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a MAP3K7 | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a Tak1 | |
| 650 | 4 | |a VETC | |
| 700 | 1 | |a Urbansky, Lana Louisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witzel, Hagen Roland |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schindeldecker, Mario |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weinmann, Arndt |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berndt, Kristina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gerber, Tiemo Sven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Köhler, Bruno Christian |d 1985- |e VerfasserIn |0 (DE-588)1018431411 |0 (DE-627)682308536 |0 (DE-576)355770288 |4 aut | |
| 700 | 1 | |a Nichetti, Federico |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ludt, Annekathrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gehrke, Nadine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schattenberg, Jörn Markus |d 1975- |e VerfasserIn |0 (DE-588)123840716 |0 (DE-627)706446542 |0 (DE-576)293903158 |4 aut | |
| 700 | 1 | |a Heinrich, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Roth, Wilfried |d 1970- |e VerfasserIn |0 (DE-588)120891557 |0 (DE-627)080951279 |0 (DE-576)292433484 |4 aut | |
| 700 | 1 | |a Straub, Beate Katharina |d 1977- |e VerfasserIn |0 (DE-588)129889377 |0 (DE-627)483342122 |0 (DE-576)188827315 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 14(2022), 2, Artikel-ID 430, Seite 1-21 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:2 |g elocationid:430 |g pages:1-21 |g extent:21 |a Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers14020430 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/14/2/430 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220921 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 129889377 |a Straub, Beate Katharina |m 129889377:Straub, Beate Katharina |d 50000 |e 50000PS129889377 |k 0/50000/ |p 15 |y j | ||
| 998 | |g 1018431411 |a Köhler, Bruno Christian |m 1018431411:Köhler, Bruno Christian |d 910000 |d 910100 |d 50000 |e 910000PK1018431411 |e 910100PK1018431411 |e 50000PK1018431411 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN1817200453 |e 4190450464 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"15 January 2022","dateIssuedKey":"2022"}],"person":[{"role":"aut","display":"Ridder, Dirk","family":"Ridder","given":"Dirk"},{"role":"aut","given":"Lana Louisa","display":"Urbansky, Lana Louisa","family":"Urbansky"},{"given":"Hagen Roland","family":"Witzel","display":"Witzel, Hagen Roland","role":"aut"},{"given":"Mario","family":"Schindeldecker","display":"Schindeldecker, Mario","role":"aut"},{"role":"aut","family":"Weinmann","display":"Weinmann, Arndt","given":"Arndt"},{"given":"Kristina","display":"Berndt, Kristina","family":"Berndt","role":"aut"},{"role":"aut","given":"Tiemo Sven","family":"Gerber","display":"Gerber, Tiemo Sven"},{"given":"Bruno Christian","family":"Köhler","display":"Köhler, Bruno Christian","role":"aut"},{"role":"aut","given":"Federico","family":"Nichetti","display":"Nichetti, Federico"},{"given":"Annekathrin","family":"Ludt","display":"Ludt, Annekathrin","role":"aut"},{"role":"aut","given":"Nadine","display":"Gehrke, Nadine","family":"Gehrke"},{"role":"aut","display":"Schattenberg, Jörn Markus","family":"Schattenberg","given":"Jörn Markus"},{"display":"Heinrich, Stefan","family":"Heinrich","given":"Stefan","role":"aut"},{"role":"aut","family":"Roth","display":"Roth, Wilfried","given":"Wilfried"},{"role":"aut","family":"Straub","display":"Straub, Beate Katharina","given":"Beate Katharina"}],"title":[{"title_sort":"Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome","title":"Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome"}],"titleAlt":[{"title":"Transforming growth factor-beta activated kinase one (Tak one) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome"}],"physDesc":[{"extent":"21 S."}],"note":["Gesehen am 21.09.2022"],"recId":"1817200453","name":{"displayForm":["Dirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Tiemo Sven Gerber, Bruno Christian Köhler, Federico Nichetti, Annekathrin Ludt, Nadine Gehrke, Jörn Markus Schattenberg, Stefan Heinrich, Wilfried Roth and Beate Katharina Straub"]},"language":["eng"],"id":{"doi":["10.3390/cancers14020430"],"eki":["1817200453"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"part":{"volume":"14","pages":"1-21","text":"14(2022), 2, Artikel-ID 430, Seite 1-21","year":"2022","extent":"21","issue":"2"},"title":[{"title":"Cancers","title_sort":"Cancers"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"MDPI","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisherPlace":"Basel"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"language":["eng"],"pubHistory":["1.2009 -"],"recId":"614095670","note":["Gesehen am 27.05.2020"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"disp":"Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcomeCancers"}]} | ||
| SRT | |a RIDDERDIRKTRANSFORMI1520 | ||